Memorial Sloan Kettering Cancer Center· @MSKCancerCenter · X·· 2026-04-21Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
Live from #AACR26: “The latest data from this small [16-person] study suggest vaccines can meaningfully stimulate the immune system in some patients with #pancreaticcancer – and these patients continue to do remarkably well years after vaccination,” says MSK physician-scientist
Heat 36 · 26 likes · 0 replies · 10 reposts
Source: Memorial Sloan Kettering Cancer Center · x.com